SFX by Ex Libris Inc.

Title:	A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis
Source:	Blood [0006-4971] Goldman, Stanton yr:2001

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Cairo, Mitchell S S. "Tumour lysis syndrome: new therapeutic strategies and classification." British journal of haematology 127.1 (2004): 3-11.
description	2.	Smalley, R V V. "Allopurinol: intravenous use for prevention and treatment of hyperuricemia." Journal of clinical oncology 18.8 (2000): 1758-63.
description	3.	Eleftheriou, Giorgio, G. "Colchicine-induced toxicity in a heart transplant patient with chronic renal failure." Clinical toxicology 46.9 (2008): 827-30.
description	4.	Pui, C H H. "Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma." Journal of clinical oncology 19.3 (2001): 697-704.
description	5.	Ruibal, A. "Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout." Arthritis and rheumatism 47.4 (2002): 356-60.
description	6.	Davidson, Martin J J. "Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome." The American journal of medicine 116.8 (2004): 546-54.
description	7.	Cairo, Mitchell S. "Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus." British journal of haematology 149.4 (2010): 578-86.
description	8.	Cope, D. "Tumor lysis syndrome." Clinical journal of oncology nursing 8.4: 415-416.
description	9.	Rampello, E. "The management of tumor lysis syndrome." Nature clinical practice. Oncology 3.8 (2006): 438-447.
description	10.	Lee, Anselm C W C. "Treatment of impending tumor lysis with single-dose rasburicase." The Annals of pharmacotherapy 37.11 (2003): 1614-7.
description	11.	Pui, C H H. "Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial." Leukemia 15.10 (2001): 1505-9.
description	12.	Coiffier, B. "Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review." Journal of clinical oncology 26.16 (2008): 2767-78.
description	13.	"Allopurinol Overuse in Asymptomatic Hyperuricemia." JAMA internal medicine. 174.7: 1031-1032.
description	14.	Spector, T. "Inhibition of urate production by allopurinol." Biochemical Pharmacology 26.5 (1977): 355-8.
description	15.	Avilés, A. "Acute tumor lysis syndrome and alkali therapy." The American journal of medicine 98.4 (1995): 417-8.
description	16.	Kuypers, Dirk R J R. "Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions." Drugs & Aging 26.9 (2009): 715-37.
description	17.	Sundov, Z. "Fatal colchicine poisoning by accidental ingestion of meadow saffron-case report." Forensic science international 149.2/3 (2005): 253-256.
description	18.	Becker, Michael A. "Determinants of the Clinical Outcomes of Gout During the First Year of Urate-Lowering Therapy." Nucleosides, nucleotides & nucleic acids 27.6/7 (2008): 585-91.
description	19.	Terkeltaub, Robert A A. "Clinical practice. Gout." The New England journal of medicine 349.17 (2003): 1647-55.
description	20.	Nuki, G. "British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout." Rheumatology 46.8 (2007): 1372-4.